| Antimicrobial Agent | Susceptibility Profile | Clinical Interpretation |
|---|---|---|
| Amikacin | Sensitive | 4 |
| Amoxicillin/Clavulanic acid | Resistant | >=32 |
| Cefepime | Resistant | >=32 |
| Cefotaxime | Resistant | >=256 |
| Ceftazidime | Resistant | 256 |
| Ceftriaxone | Resistant | >=64 |
| Cefuroxime | Resistant | >=64 |
| Ciprofloxacin | Resistant | >=4 |
| Colistin | Intermediate | 1 |
| Ertapenem | Resistant | >=8 |
| Fosfomycin | Resistant | >=256 |
| Gentamicin | Sensitive | <=1 |
| Imipenem | Resistant | 4 |
| Levofloxacin | Resistant | 128 |
| Meropenem | Resistant | >=16 |
| Nitrofurantoin | Resistant | 256 |
| Piperacillin/Tazobactam | Resistant | >=128 |
| Tobramycin | Intermediate | 8 |
| Trimethoprim/Sulfamethoxazole | Resistant | 160 |
| Resistant Gene Track | Detection Methodology | NCBI Genome Accession |
|---|---|---|
| aac-6'-Ib-cr | PCR | |
| blaCTXM-group1 | PCR | |
| blaoxa-1 | PCR | |
| blaoxa48-like | PCR | |
| blaSHV | PCR | |
| oqxA | PCR | |
| oqxB | PCR |